COMP <GO>
DLB vs BRK-A // EV/EBITDA & P/E VALUATION
Dolby Laboratories (NYSE) VS. Berkshire Hathaway Inc. (Class A) (NYSE) • 15-METRIC TALLY: DLB 5
— BRK-A 7
▲ EV/EBITDA & P/E VALUATION LEADER: BRK-A
LAST: $62.91 (+2.01%) • MKT CAP: $5.89B
valuation
18.6x
LAST: $817,500.00 (+0.68%) • MKT CAP: $1.20T
valuation
9.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DLB VS. BRK-A)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DLB | BRK-A | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.50% | 11.47% | -1.97 | BRK-A | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.6x | 9.7x | +8.92 | BRK-A | /valuation <GO> |
| Free Cash Flow Yield | 7.40% | 2.09% | +5.31 | DLB | /fcf-yield <GO> |
| Operating Margin | 19.60% | 27.80% | -8.20 | BRK-A | /operating-margins <GO> |
| Net Profit Margin | 18.90% | 22.30% | -3.40 | BRK-A | /net-margins <GO> |
| Revenue Growth (YoY) | 5.90% | 3.93% | +1.97 | DLB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.15% | 0.00% | +2.15 | DLB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | DLB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.5 | 68.1 | -8.60 | BRK-A | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 1.13 | -0.13 | BRK-A | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.5x | 24.3x | -2.84 | DLB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.89B | $1.20T | -$1.20T | BRK-A | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DLB REV | BRK-A REV | DLB GROSS % | BRK-A GROSS % | DLB FCF | BRK-A FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.35B | $247.24B | 88.1% | — | $435.9M | $25.04B |
| FY 2024 | $1.27B | $249.71B | 89.0% | — | $297.2M | $11.62B |
| FY 2023 | $1.30B | $254.91B | — | — | $308.6M | $37.73B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DLB // BETA 1.00
BRK-A // BETA 1.13